MENLO PARK, Calif.--(BUSINESS WIRE)--Calysta, Inc. (www.calysta.com), today announced the company has achieved 8-fold improved performance over traditional fermentation technologies in a high mass transfer bioreactor. The bioreactor technology is under development for efficient methane-to-liquids fermentation processes, enabling rapid, cost-effective methane conversion into protein, industrial chemicals and fuels.
Help employers find you! Check out all the jobs and post your resume.
